£180.00

De Gruyter Metallo-Drugs: Development and Action of Anticancer Agents (Metal Ions in Life Sciences): 18

Price data last checked 10 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£180 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 81 days · 81 data points (no recent data)

Historical
Generating forecast…
£180.00 £171.00 £174.60 £178.20 £181.80 £185.40 £189.00 26 June 2026 16 July 2026 05 August 2026 25 August 2026 14 September 2026

Price Distribution

Price distribution over 81 days • 1 price levels

Days at Price
81 days 0 20 41 61 81 £180 Days at Price

Price Analysis

Most common price: £180 (81 days, 100.0%)

Price range: £180 - £180

Price levels: 1 different prices over 81 days

Description

Volume 18, entitled Metallo-Drugs: Development and Action of Anticancer Agents of the series Metal Ions in Life Sciences centers on biological, medicinal inorganic chemistry. The serendipitous discovery of the antitumor activity of cis-diamminodichloroplatinum(II) (cisplatin) by Barnett Rosenberg in the 1960s is a landmark in metallodrug-based chemotherapy. The success of cisplatin in the clinic, followed by oxaliplatin and carboplatin, along with their drawbacks relating mainly to resistance development and severe toxicity, initiated research on polynuclear platinum complexes and on Pt(IV) complexes as prodrugs. Furthermore, the indicated shortcomings led to the exploration of other transition and main group metal ions, among them Ru(II/III), Au(I/III), Ti(IV), V(IV/V), and Ga(III) including also the essential metal ions Fe(II/III), Cu(I/II), and Zn(II). Ionic as well as covalent and non-covalent interactions between structurally very different complexes and biomolecules like nucleic acids, proteins, and carbohydrates are studied and discussed with regard to their possible anticancer actions. Hence, MILS-18 summarizes the research at the forefront of medicinal inorganic chemistry, including studies on the next-generation, tailor-made anticancer drugs. All this and more is treated in an authoritative and timely manner in the 17 stimulating chapters of this book, written by 39 internationally recognized experts from 10 nations (from the US via Europe to China and Australia). The impact of this vibrant research area is manifested by more than 2700 references, nearly 150 illustrations (more than half in color) and several comprehensive tables. Metallo-Drugs: Development and Action of Anticancer Agents is an essential resource for scientists working in the wide range from enzymology, material sciences, analytical, organic, and inorganic biochemistry all the way through to medicine including the clinic ... not forgetting that it also provides excellent information for teaching.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
05 February 2018
Listed Since
15 February 2017

Barcode

No barcode data available

Similar Products You Might Like

Ruthenium and Other Non-Platinum Metal Complexes in Cancer Chemotherapy: 10 (Progress in Clinical Biochemistry and Medicine, 10)
82% match

Ruthenium and Other Non-Platinum Metal Complexes in Cancer Chemotherapy: 10 (Progress in Clinical Biochemistry and Medicine, 10)

Springer

£113.97 07 Aug 2026
Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2
80% match

Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2

Springer

£145.87 07 Aug 2026
Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II): Thiol “Switch-on” Fluorescent Probes, Thioredoxin Reductase ... Reticulum Targeting Agents (Springer Theses)
79% match

Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II): Thiol “Switch-on” Fluorescent Probes, Thioredoxin Reductase ... Reticulum Targeting Agents (Springer Theses)

Springer

£74.98 07 Aug 2026
Cisplatin: Pharmacology, Clinical Uses & Adverse Effects (Pharmacology - Research, Safety Testing and Regulation: Cancer Etiology, Diagnosis and Treatments)
79% match

Cisplatin: Pharmacology, Clinical Uses & Adverse Effects (Pharmacology - Research, Safety Testing and Regulation: Cancer Etiology, Diagnosis and Treatments)

£86.54 14 Sep 2026
Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications (Cancer Drug Discovery and Development)
79% match

Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications (Cancer Drug Discovery and Development)

Humana

£147.14 04 Aug 2026
Metallothioneins and Related Chelators (Metal Ions in Life Sciences): 5
79% match

Metallothioneins and Related Chelators (Metal Ions in Life Sciences): 5

De Gruyter

£74.99 30 Aug 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
79% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£74.57 08 Aug 2026
Cancer Drug Discovery: Science and History
79% match

Cancer Drug Discovery: Science and History

Springer

£113.76 05 Aug 2026
Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine
79% match

Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine

Wiley

£64.21 14 Sep 2026
Metallopharmaceuticals I: DNA Interactions: 1 (Topics in Biological Inorganic Chemistry)
78% match

Metallopharmaceuticals I: DNA Interactions: 1 (Topics in Biological Inorganic Chemistry)

Springer

£165.28 18 Aug 2026
Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)
78% match

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Springer

£107.85 06 Aug 2026
Fate and Effects of Anticancer Drugs in the Environment
78% match

Fate and Effects of Anticancer Drugs in the Environment

Springer

£104.76 31 Aug 2026
New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)
78% match

New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)

Springer

£77.88 06 Aug 2026
Molecular Therapies of Cancer
78% match

Molecular Therapies of Cancer

Springer

£108.35 31 Aug 2026
Handbook of Metallonutraceuticals (Nutraceuticals)
78% match

Handbook of Metallonutraceuticals (Nutraceuticals)

CRC Press

£91.99 17 Aug 2026
Cancer Drug Design and Discovery
78% match

Cancer Drug Design and Discovery

Academic Press

£84.89 07 Aug 2026
Natural Products and Cancer Drug Discovery (Cancer Drug Discovery and Development)
78% match

Natural Products and Cancer Drug Discovery (Cancer Drug Discovery and Development)

Humana

£107.98 05 Aug 2026
Cancer II: 28 (Topics in Medicinal Chemistry, 28)
78% match

Cancer II: 28 (Topics in Medicinal Chemistry, 28)

Springer

£199.19 04 Aug 2026
78% match

Phytochemicals in Cancer Therapy and Beyond

Elsevier

£138.00 14 Sep 2026
Molecular and Cellular Biology of Multidrug Resistance in Tumour Cells
78% match

Molecular and Cellular Biology of Multidrug Resistance in Tumour Cells

Springer

£67.00 18 Aug 2026
Catalytic Activation of Dioxygen by Metal Complexes: 13 (Catalysis by Metal Complexes, 13)
78% match

Catalytic Activation of Dioxygen by Metal Complexes: 13 (Catalysis by Metal Complexes, 13)

Springer

£160.14 29 Jul 2026
Bioinorganic Chemistry: 70 (Structure and Bonding, 70)
78% match

Bioinorganic Chemistry: 70 (Structure and Bonding, 70)

Springer

£113.76 05 Aug 2026
Heterocyclic Anticancer Agents
78% match

Heterocyclic Anticancer Agents

De Gruyter

£189.25 30 Aug 2026
Drug Discovery in Pancreatic Cancer: Models and Techniques
77% match

Drug Discovery in Pancreatic Cancer: Models and Techniques

Springer

£108.01 06 Aug 2026